Stockscreener 앱 받기
103.98
8.60%
8.23
시간 외 거래:
104.83
0.85
+0.82%
전일 마감가:
$95.75
열려 있는:
$96.33
하루 거래량:
801.30K
Relative Volume:
0.76
시가총액:
$4.05B
수익:
$117.67M
순이익/손실:
$-1.88B
주가수익비율:
-1.7176
EPS:
-60.5369
순현금흐름:
$-621.36M
1주 성능:
+21.90%
1개월 성능:
+2.97%
6개월 성능:
+122.56%
1년 성능:
+428.62%
1일 변동 폭
$96.00
$104.91
1주일 범위
$84.08
$104.91
52주 변동 폭
$16.56
$115.76
Grail Inc Stock (GRAL) Company Profile
명칭
Grail Inc
전화
(833) 694-2553
주소
1525 O'BRIEN DRIVE, MENLO PARK
GRAL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GRAL
Grail Inc
|
103.98 | 3.73B | 117.67M | -1.88B | -621.36M | -60.54 |
|
TMO
Thermo Fisher Scientific Inc
|
620.72 | 229.63B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
236.59 | 166.25B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
706.83 | 54.48B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
147.60 | 40.52B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
240.53 | 39.95B | 15.90B | 1.28B | 2.21B | 7.2842 |
Grail Inc Stock (GRAL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 재개 | Morgan Stanley | Equal-Weight |
| 2025-11-12 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2025-04-21 | 개시 | Canaccord Genuity | Buy |
| 2024-11-27 | 개시 | Morgan Stanley | Equal-Weight |
| 2024-11-15 | 개시 | Wolfe Research | Peer Perform |
| 2024-10-17 | 개시 | Guggenheim | Neutral |
모두보기
Grail Inc 주식(GRAL)의 최신 뉴스
GRAIL (GRAL) Is Up 12.3% After Samsung-Backed Asian Galleri Deal And Trial DataHas The Bull Case Changed? - simplywall.st
Why Illumina (ILMN) Is Up 6.5% After Advancing Grail Divestiture Plan And What's Next - Yahoo Finance UK
Avoiding Lag: Real-Time Signals in (GRAL) Movement - Stock Traders Daily
Should Illumina’s (ILMN) Grail Spinoff to Ease Regulatory Pressure Require Action From Investors? - simplywall.st
Assessing GRAIL (GRAL) Valuation After Pathfinder 2 Success and Samsung’s Asian Galleri Deal - simplywall.st
Small-Cap Standouts: These 3 Stocks Rose Over 300% in 2025 - Finviz
Grail Inc (GRAL) Climbs 380% on Strong Optimism for Cancer Detection Kit - Insider Monkey
GRAIL Earnings Notes - Trefis
Samsung and GRAIL Announce Strategic Collaboration To Bring GRAIL’s Galleri® Multi-Cancer Early Detection Test to Asia - samsung.com
GRAIL stock drops in New York session as Galleri FDA filing timeline returns to focus - ts2.tech
Legal Advantage Investments Inc. Invests $1.24 Million in GRAIL, Inc. $GRAL - MarketBeat
Early Cancer Detection Firm Grail Leads Nasdaq Gainers as Stock Jumps 20% - MSN
Morgan Stanley Eyes Emerging Growth for Grail (GRAL) as Sector Valuations Reach Equilibrium - Insider Monkey
Morgan Stanley eyes emerging growth for Grail (GRAL) as sector valuations reach equilibrium - MSN
GRAIL: Making Strides In Cancer Detection (NASDAQ:GRAL) - Seeking Alpha
Carnegie Investment Counsel Increases Stake in GRAIL, Inc. $GRAL - MarketBeat
Blood test finds seven times more cancers than standard screenings - OHSU News
(GRAL) Risk Channels and Responsive Allocation - Stock Traders Daily
Archaeopteryx | The Holy Grail of Fossils at the Field Museum - Britannica
Sheets Smith Investment Management Takes $1.69 Million Position in GRAIL, Inc. $GRAL - MarketBeat
GRAL Stock: Cancer Detection Firm Targets Further Upside After 381% Rally - CMC Markets
Why Fusion Is Considered Energy’s Elusive Holy Grail - The Wall Street Journal
Westwood Holdings Group Inc. Has $899,000 Holdings in GRAIL, Inc. $GRAL - MarketBeat
How Recent Catalysts Are Shifting the Narrative for GRAIL - Yahoo Finance
GRAIL to Present at the 44th Annual J.P. Morgan Healthcare Conference - The AI Journal
NWF Advisory Services Inc. Makes New $1.06 Million Investment in GRAIL, Inc. $GRAL - MarketBeat
64,560 Shares in GRAIL, Inc. $GRAL Bought by Caxton Associates LLP - MarketBeat
Trading the Move, Not the Narrative: (GRAL) Edition - news.stocktradersdaily.com
Here's Why Grail Soared, Again, in November - AOL.com
BBR Partners LLC Sells 35,000 Shares of GRAIL, Inc. $GRAL - MarketBeat
GRAIL (GRAL) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
GRAIL : Non-Invasive Urinary Detection of Upper Tract Urothelial Carcinoma via Methylation Patterns in Cell-Free DNA View Presentation - marketscreener.com
Rhumbline Advisers Has $2.54 Million Holdings in GRAIL, Inc. $GRAL - MarketBeat
Jim Cramer Says “Salesforce Now Has The Holy Grail” - Yahoo Finance
Insider Sell: Joshua Ofman Sells 13,000 Shares of GRAIL Inc (GRA - GuruFocus
GRAIL (GRAL) Price Target Increased by 16.67% to 107.10 - Nasdaq
Grail Insider Sold Shares Worth $2,478,818, According to a Recent SEC Filing - marketscreener.com
Grail Insider Sold Shares Worth $3,809,535, According to a Recent SEC Filing - marketscreener.com
Will GRAIL Inc. (NL0) stock draw ESG focused fundsQuarterly Trade Review & Long-Term Growth Portfolio Plans - Newser
Here's Why Grail Stock Exploded Higher by 55% in October - AOL.com
Will GRAIL Inc. (NL0) stock attract long term capital inflows2025 Macro Impact & AI Forecasted Stock Moves - Newser
CFO Freidin Files To Sell 25,000 Of Grail Inc [GRAL] - TradingView
Grail: Downgraded From Speculative Buy To Hold As The Stock Price Appreciated Faster Than Expected - Seeking Alpha
(GRAL) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
Creative Planning Takes $725,000 Position in GRAIL, Inc. $GRAL - MarketBeat
GRAIL (NASDAQ:GRAL) Stock Price Down 6.7%What's Next? - MarketBeat
GRAL: Morgan Stanley Raises Price Target to $110, Maintains Equa - GuruFocus
Is GRAIL Inc. (NL0) stock undervalued historically2025 Technical Overview & Free Risk Controlled Daily Trade Plans - Newser
How GRAIL Inc. (NL0) stock responds to job market shifts2025 Price Action Summary & Intraday High Probability Setup Alerts - Newser
Will GRAIL Inc. (NL0) stock benefit from mergersMarket Sentiment Review & Free Safe Capital Growth Stock Tips - Newser
Morgan Stanley Raises Price Target on GRAIL to $110 From $85, Keeps Equalweight Rating - marketscreener.com
Grail Inc (GRAL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.85%
자본화:
|
볼륨(24시간):